Skip to content
Screener

Reported August 12, 2025 · After market close

Revenue$303.3KBeat by $103.3K
EPS-$0.30Beat by $0.11
Revenue estimate$200.0K
EPS estimate-$0.41

Next report

Sep 22, 2026 (In 4 days)
Revenue estimate$600.0K
EPS estimate-$2.00

FAQ

When did BioRestorative Therapies report Q2 2025 earnings?
BioRestorative Therapies (BRTX) reported Q2 2025 earnings on August 12, 2025 after market close.
What were BioRestorative Therapies's Q2 2025 revenue and EPS?
BioRestorative Therapies reported revenue of $303.3K and eps of $-0.30 for Q2 2025.
Did BioRestorative Therapies beat estimates in Q2 2025?
Revenue beat the consensus estimate of $200.0K by $103.3K. EPS beat the consensus estimate of $-0.41 by $0.11.
How did BioRestorative Therapies's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 240.4% from $89.1K a year earlier and eps grew 40.0% from $-0.50.
Where can I find BioRestorative Therapies's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001021771-25-000113) and the 10-Q periodic report (0001641172-25-023211) directly on SEC EDGAR. The filing index links above go to sec.gov.